IZURALIMAB

UNII:	9D2R4T39AY
Formula:
Preferred Substance Name:	IZURALIMAB
GSRS Full Record:	9D2R4T39AY i

2329669-80-7
IMMUNOGLOBULIN HALF-IG G1-KAPPA/SCFV-H-CH2-CH3, ANTI-(HOMO SAPIENS ICOS (INDUCIBLE T-CELL COSTIMULATORY, ACTIVATION-INDUCIBLE LYMPHOCYTE IMMUNOMEDIATORY MOLECULE, AILIM, CD278)) AND ANTI-(HOMO SAPIENS PDCD1 (PROGRAMMED CELL DEATH 1, PD-1, PD1, CD279)), MONOCLONAL ANTIBODY, BISPECIFIC
IMMUNOGLOBULIN, ANTI-(HUMAN PROGRAMMED CELL DEATH 1) (HUMAN-MUS MUSCULUS MONOCLONAL XMAB23104 SINGLE-CHAIN VARIABLE FRAGMENT VL-LINKER-VH) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN C-REGION C-TERMINAL FRAGMENT), (260->234'),(263->237')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN G1-ANTI-(HUMAN INDUCIBLE COSTIMULATOR) (HUMAN MONOCLONAL XMAB23104 .GAMMA.1-CHAIN) DISULFIDE WITH HUMAN MONOCLONAL XMAB23104 .KAPPA.-CHAIN
IZURALIMAB [INN]
IZURALIMAB [USAN]
IZURALIMAB [WHO-DD]
XMAB23104
XMAB-23104

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

IZURALIMAB

Synonyms and Mappings

Resources